APOE-epsilon 4 is associated with less frontal and more medial temporal lobe atrophy in AD

Objective: To test the hypothesis that the epsilon 4 allele of APOE is asso ciated with a region-specific pattern of brain atrophy in AD. Methods: Volu mes of the hippocampi, entorhinal cortices, and anterior temporal and front al lobes were measured in 28 mild to moderate AD patients and 30 controls u sing MRI, Within the AD group, 14 patients were noncarriers (-/-), 9 were h eterozygous (epsilon 4/-), and 5 were homozygous (epsilon 4/4) for the epsi lon 4 allele, Dementia severity was similar across the three AD groups. Res ults: Smaller volumes were found with increasing dose of the epsilon 4 alle le in the hippocampus, entorhinal cortex, and anterior temporal lobes in AD patients. When compared with controls, the volume loss in the right and le ft temporal regions ranged from -15.3 to -22.7% in the -/- AD group, from - 26.2 to -36.0% in the epsilon 4/- group, and from -24.0 to -48.0% in the ep silon 4/4 group (p < 0.0005). In contrast, larger volumes were found in the frontal lobes with increasing epsilon 4 gene dose. When compared with cont rols, volume differences of the right: frontal lobe were -11.8% in the -/- AD group, -8.5 in the epsilon 4/- group, and -1.4% in the epsilon 4/4 group (p = 0.03). Conclusions: We found smaller volumes in the temporal lobe reg ions but larger volumes in the frontal lobes with increasing APOE-epsilon 4 gene dose in AD patients. These data suggest a region-specific biological effect of the epsilon 4 allele in the brains of AD patients.